We can't find the internet
Attempting to reconnect
44271.1 IP-LS
44271.1 IP-LS
Zusammenfassung
EZH2 Inhibitors: a new treatment opportunity with disease modifying potential for people with hereditary blindness
Weitere Texte
Abstract
No generic treatments are available for inherited retinal dystrophies resulting in blindness. We found that the inhibition of an enzyme involved in epigenetic modifications markedly improved cell survival, so we aim to determine the best existing drug to delay blindness in human in the near future.
Beteiligte
Yvan Arsenijevic
Kontaktperson
yvan.arsenijevic@fa2.ch
Fondation Asile des aveugles Yvan Arsenijevic Av. de France 15 1004 Lausanne VD CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2020-05-31
- Enddatum
- 2022-03-31
- Bewilligte Gesamtkosten
- CHF 356229.26
- Sektion
- 60 Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T410 Pharmaceuticals and related technologies 100.0%